Cargando…
From micro to nano: evolution and impact of drug delivery in treating disease
Over the past 50 years, drug delivery breakthroughs have enabled the approval of several important medicines. Often, this path starts with innovation from academic collaborations amongst biologists, chemists, and engineers, followed by the formation of a start-up company driving clinical translation...
Autores principales: | Hrkach, Jeff, Langer, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209970/ https://www.ncbi.nlm.nih.gov/pubmed/32385828 http://dx.doi.org/10.1007/s13346-020-00769-6 |
Ejemplares similares
-
Innovations in vaccine delivery: increasing access, coverage, and equity and lessons learnt from measles and rubella elimination
por: Goodson, James L., et al.
Publicado: (2022) -
Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine
por: Milane, Lara, et al.
Publicado: (2021) -
Regulatory safety evaluation of nanomedical products: key issues to refine
por: De Jong, Wim H., et al.
Publicado: (2022) -
Contraceptive technologies for global health: ethically getting to safe, effective and acceptable options for women and men
por: Townsend, John, et al.
Publicado: (2020) -
Trajectories in nanotechnology: embracing complexity, seeking analogies
por: Florence, Alexander T.
Publicado: (2021)